H-EGVLYVGSK-OH

Rif. 3D-PP41480

Informazioni sul prodotto

• Nome: H-EGVLYVGSK-OH

Descrizione

Peptide H-EGVLYVGSK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EGVLYVGSK-OH include the following: The involvement of dityrosine crosslinking in alpha-synuclein assembly and deposition in Lewy Bodies in Parkinson's disease YK Al-Hilaly , L Biasetti , BJF Blakeman, SJ Pollack - Scientific reports, 2016 - nature.comhttps://www.nature.com/articles/srep39171 Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic W Xiang , JCM Schlachetzki , S Helling - Molecular and Cellular , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S104474311300016X Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration TM Dawson , HS Ko - researchgate.nethttps://www.researchgate.net/profile/Preston-Ge/publication/304493840_Activation_of_tyrosine_kinase_c-Abl_contributes_to_-synuclein-induced_neurodegeneration/links/577270ce08aeeec38953e0e3/Activation-of-tyrosine-kinase-c-Abl-contributes-to-synuclein-induced-neurodegeneration.pdf Characterization and identification of dityrosine cross-linked peptides using tandem mass spectrometry S Mukherjee , EA Kapp , A Lothian, AM Roberts - Analytical , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b00941 Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration S Brahmachari, P Ge , SH Lee , D Kim - The Journal of , 2016 - Am Soc Clin Investighttps://www.jci.org/articles/view/85456 A novel strategy for the targeted analysis of protein and peptide metabolites NA Williamson , C Reilly , CT Tan - , 2011 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201000474 A novel strategy for the targeted analysis of protein and peptide metabolites N Williamson , C Reilly , CT Tan , SH Ramarathinam - Nature , 2009 - nature.comhttps://www.nature.com/articles/npre.2009.3812.1 Absolute quantification of synuclein proteoforms in plasma in patients with Synucleinopathies by LC-MRM mass spectrometry ML PONS, M Vignon, J Vialaret , E Mondesert - medRxiv, 2023 - medrxiv.orghttps://www.medrxiv.org/content/10.1101/2023.07.17.23292753.abstract Development of a novel method for the quantification of tyrosine 39 phosphorylated alpha-and beta-synuclein in human cerebrospinal fluid CH Na , G Sathe , LS Rosenthal , AR Moghekar - Clinical proteomics, 2020 - Springerhttps://link.springer.com/article/10.1186/s12014-020-09277-8 Development of a novel method for the quantification of tyrosine 39 phosphorylated a-and beta-synuclein in human cerebrospinal fluid CH Na , G Sathe , LS Rosenthal , AR Moghekar - 2020 - researchsquare.comhttps://www.researchsquare.com/article/rs-10700/latest alpha-Synuclein aggregation in the saliva of familial transthyretin amyloidosis: a potential biomarker A Guerreiro , G da Costa, RA Gomes , C Ribeiro-Silva - Amyloid, 2012 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.3109/13506129.2012.668500

• Marchio: Biosynth